Tirzepatide 15mg

Also known as mounjaro.

Tirzepatide has a dual approach with both GLP and GIP benefits. Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, which means it mimics the action of these incretin hormones to enhance insulin secretion, suppress glucagon release, and slow gastric emptying. This multifaceted approach helps improve blood sugar control, promotes weight loss, and reduces the risk of cardiovascular events in diabetic patients. Tirzepatide has shown promising results in clinical trials, offering a new therapeutic option for those struggling to achieve glycemic control with existing treatments.

Dosage and Frequency
Once a week
Taken on the same day each week, any time of day, with or without food.